(9 days)
Not Found
Not Found
No
The summary describes an electrosurgical generator for cutting and coagulation, with no mention of AI, ML, image processing, or data analysis that would typically indicate AI/ML functionality.
Yes
The device is used for cutting and coagulation of human tissue, which are therapeutic actions performed during surgical procedures.
No
The document states the device is an electrosurgical generator for cutting and coagulation of human tissue during surgical procedures, which are therapeutic actions, not diagnostic.
No
The device is described as an "Electrosurgical Generator," which is a hardware device used for cutting and coagulation of tissue. The summary does not mention any software component as the primary or sole function.
Based on the provided information, the BOVIE Model X15 Electrosurgical Generator is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "cutting and coagulation of human tissue" during "laparoscopic surgical procedures." This describes a device used on the patient's body during surgery, not a device used to test samples outside the body (in vitro).
- Device Description: While the description is "Not Found," the intended use clearly points to a surgical device.
- Lack of IVD Characteristics: The information does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue samples, etc.)
- Providing diagnostic information about a patient's health status
- Using reagents or assays
Electrosurgical generators are considered surgical devices used for therapeutic purposes, not diagnostic purposes.
N/A
Intended Use / Indications for Use
The BOVIE Model X15 Electrosurgical Generator is Indicated for Use in laparoscopic surgical procedures for the cutting and coagulation of human tissue.
The BOVIE Model X15 can be used in conjunction with the appropriate accessories and instruments for applications in General Surgery.
Product codes
GEI
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
human tissue
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the department's name around the perimeter. Inside the circle is an abstract image of an eagle or bird-like figure. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 18 1997
Maxxim Medical c/o Mr. Michael A. Clark South East Regulatory Associates, Inc. ---------1070 Thornwood Lane Dacula, Georgia 30211-3007
乐
Re: K972161 Trade Name: BOVIE Model X15 Regulatory Class: II Product Code: GEI Dated: June 2, 1997 Received: June 9, 1997
Dear Mr. Clark:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
1
Page 2 - Mr. Michael A. Clark
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. . . . . . . . . . . .
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and at vertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Joelle
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
510(k) Notification BOVIE Model X15 Electrosurgical Generator June 2, 1997
INDICATIONS FOR USE
The BOVIE Mođel X15 Electrosurgical Generator is Indicated for Use ´ ' V in laparoscopic surgical procedures for the cutting and coagulation of human tissue.
The BOVIE Model X15 can be used in conjunction with the appropriate accessories and instruments for applications in General Surgery.
| Concurrence of CDRH, Office of Device Evaluation (ODE) | |
|---|---|
| (Fraser Sign Off) Restorative Devices | |
| K972161 | |
| Prescription Use | |
| (Per 21 CFR 801.109) | X |
| OR | |
| Over-The-Counter Use |